QNCX Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Quince Therapeutics Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerQNCX

Market Cap18.7M

Cash RunwayRunway 6-12 months

Next Catalystn/a

Public Research Snapshot

Quince Therapeutics Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for Dexamethasone sodium phosphate in Ataxia Telangiectasia (Phase 3).

Pipeline

Asset	Indication	Modality	Stage	Public Note
COR388 capsule	Alzheimer Disease	n/a	Phase 2 \| Phase 3	Public pipeline row
Dexamethasone sodium phosphate	Ataxia Telangiectasia	n/a	Phase 3	Public pipeline row

Catalyst Preview

No public catalyst rows matched this view yet.

Cash Runway Preview

Estimated cash runway: Runway 6-12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT03823404	Phase 2 \| Phase 3	COMPLETED	643	2022-01-01
NCT06664853	Phase 3	TERMINATED	101	2026-01-30

Scientific Context

literature_publication | Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison.
literature_publication | Efficacy and Safety of Ecopipam for Tourette Syndrome: A Phase 3 Randomized Clinical Trial.
literature_publication | A Randomized, Double-Blind, Pilot Study of N-Acetylcysteine for Motor and Cognitive Symptoms in Youth With Neurofibromatosis Type 1.
literature_publication | Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome.
literature_publication | Brexpiprazole for treating agitation in different groups of people with Alzheimer's dementia: a plain language summary.

Want the full QNCX research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.